ARK Genomic Revolution ETF vs 10X Genomics Inc — how do they compare? ARK Genomic Revolution ETF trades at $44.36, while 10X Genomics Inc trades at $59.23 (market cap $7.61B). Which is the better fit depends on your goals.
| ARKG | TXG | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $44.55 | $58.57 |
52-Week Low | $24.02 | $11.34 |
Market Cap | — | $7.61B |
Enterprise Value | — | $7.14B |
Trailing returns across standard periods
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →